Down-regulation of beta3-adrenergic receptor expression in rat adipose tissue during the fasted/fed transition: evidence for a role of insulin

Biochem J. 1997 Apr 15;323 ( Pt 2)(Pt 2):359-64. doi: 10.1042/bj3230359.

Abstract

The beta3-adrenergic receptor (beta3-AR) exerts a central role in the transduction of catecholamine effects in white and brown adipose tissue (WAT and BAT). A recent report has documented that insulin strongly down-regulates beta3-AR expression and catecholamine responsiveness in 3T3-F442A adipocytes [Fève, El Hadri, Quignard-Boulangé and Pairault (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 5677-5681]. In the present report we show that the rise in plasma insulin levels elicited by the fasted/fed transition is associated with a reduction in beta3-AR mRNA levels and beta-adrenergic responsiveness in WAT and BAT. beta3-AR transcripts are also decreased in adipose tissue from animals subjected for 6 h to euglycaemic hyperinsulinaemic glucose clamps. Moreover, insulin acts directly on cultured rat white and brown adipocytes to decrease beta3-AR gene expression and adenylate cyclase activity in response to beta3-AR-selective agonists. These results suggest that there is a close relationship between food intake, plasma insulin levels and beta3-AR expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Adenylyl Cyclase Inhibitors
  • Adipocytes / metabolism*
  • Adipose Tissue, Brown / metabolism
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Eating
  • Ethanolamines / pharmacology
  • Fasting
  • Insulin / blood*
  • Mice
  • Propanolamines / pharmacology
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, beta / metabolism*
  • Receptors, Adrenergic, beta-3

Substances

  • Adenylyl Cyclase Inhibitors
  • Adrenergic beta-Agonists
  • Ethanolamines
  • Insulin
  • Propanolamines
  • RNA, Messenger
  • Receptors, Adrenergic, beta
  • Receptors, Adrenergic, beta-3
  • BRL 37344
  • CGP 12177